BG61894B2 - Метод за получаване на 1 бета-етил-1 алфа-(хидроксиметил)- 1,2,3,4,6,7,12,12в алфа-октахидор-индоло/2,3-а/-хинолизин и нови междинни съединения - Google Patents
Метод за получаване на 1 бета-етил-1 алфа-(хидроксиметил)- 1,2,3,4,6,7,12,12в алфа-октахидор-индоло/2,3-а/-хинолизин и нови междинни съединения Download PDFInfo
- Publication number
- BG61894B2 BG61894B2 BG098289A BG9828993A BG61894B2 BG 61894 B2 BG61894 B2 BG 61894B2 BG 098289 A BG098289 A BG 098289A BG 9828993 A BG9828993 A BG 9828993A BG 61894 B2 BG61894 B2 BG 61894B2
- Authority
- BG
- Bulgaria
- Prior art keywords
- formula
- indolo
- ethyl
- hydroxymethyl
- hexahydro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 24
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 10
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 8
- 229920002866 paraformaldehyde Polymers 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 5
- 239000012458 free base Substances 0.000 claims description 5
- 238000002955 isolation Methods 0.000 claims description 4
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 239000012279 sodium borohydride Substances 0.000 claims description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- BKRBRZLECKMEBD-UHFFFAOYSA-N (1-ethyl-3,4,6,7,12,12b-hexahydro-2h-indolo[2,3-a]quinolizin-1-yl)methanol Chemical compound C1=CC=C2C(CCN3CCCC(C43)(CO)CC)=C4NC2=C1 BKRBRZLECKMEBD-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 2
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 23
- 239000007858 starting material Substances 0.000 description 9
- -1 β-ethyl Chemical class 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 5
- MTEOGEBTRZOKPM-UHFFFAOYSA-N 1-ethyl-2,3,4,6,7,12-hexahydroindolo[2,3-a]quinolizine Chemical compound N1C2=CC=CC=C2C2=C1C1=C(CC)CCCN1CC2 MTEOGEBTRZOKPM-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- VUWFVAPKKYSYLJ-UHFFFAOYSA-N (1-ethyl-3,4,6,7-tetrahydro-2h-indolo[2,3-a]quinolizin-1-yl)methanol Chemical compound C1=CC=CC2=NC3=C4C(CC)(CO)CCCN4CCC3=C21 VUWFVAPKKYSYLJ-UHFFFAOYSA-N 0.000 description 1
- NAAHLZIEASNUHH-UHFFFAOYSA-N 1,2,3,4,6,7-hexahydroindolo[2,3-a]quinolizin-1-ylmethanol Chemical compound C1=CC=CC2=NC3=C4C(CO)CCCN4CCC3=C21 NAAHLZIEASNUHH-UHFFFAOYSA-N 0.000 description 1
- JAZGHAQJAKZVMY-UHFFFAOYSA-N 1-ethyl-2,3,3a,4,5,6-hexahydroindole Chemical compound C(C)N1CCC2CCCC=C12 JAZGHAQJAKZVMY-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000005042 acyloxymethyl group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU906952A HU207070B (en) | 1990-10-31 | 1990-10-31 | Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine |
Publications (1)
Publication Number | Publication Date |
---|---|
BG61894B2 true BG61894B2 (bg) | 1998-08-31 |
Family
ID=10972062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG098289A BG61894B2 (bg) | 1990-10-31 | 1993-12-10 | Метод за получаване на 1 бета-етил-1 алфа-(хидроксиметил)- 1,2,3,4,6,7,12,12в алфа-октахидор-индоло/2,3-а/-хинолизин и нови междинни съединения |
Country Status (21)
Country | Link |
---|---|
US (1) | US5352790A (no) |
EP (1) | EP0507914A1 (no) |
JP (1) | JPH05503297A (no) |
KR (1) | KR100211445B1 (no) |
CN (1) | CN1040439C (no) |
BG (1) | BG61894B2 (no) |
CA (1) | CA2071878A1 (no) |
CZ (1) | CZ280718B6 (no) |
FI (1) | FI923042A0 (no) |
GE (1) | GEP19981536B (no) |
HU (1) | HU207070B (no) |
LT (1) | LT3733B (no) |
LV (1) | LV10272B (no) |
NO (1) | NO300688B1 (no) |
PL (1) | PL168526B1 (no) |
RO (1) | RO109650B1 (no) |
RU (1) | RU2056423C1 (no) |
SK (1) | SK279484B6 (no) |
TW (1) | TW223074B (no) |
WO (1) | WO1992007851A1 (no) |
ZA (1) | ZA918790B (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010057055A2 (en) * | 2008-11-13 | 2010-05-20 | Halliburton Energy Services, Inc. | Downhole instrument calibration during formation survey |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU167366B (no) * | 1972-09-06 | 1975-09-27 | ||
GB1499546A (en) * | 1974-05-07 | 1978-02-01 | Richter Gedeon Vegyeszet | Indolo-quinolizidine derivatives and a process for the preparation thereof |
HU170495B (no) * | 1974-05-07 | 1977-06-28 | ||
US4044012A (en) * | 1974-05-07 | 1977-08-23 | Richter Gedeon Vegyeszeti Gyar Rt. | Indolo-quinolizidine derivatives |
HU194221B (en) * | 1985-04-19 | 1988-01-28 | Richter Gedeon Vegyeszet | Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound |
-
1990
- 1990-10-31 HU HU906952A patent/HU207070B/hu not_active IP Right Cessation
-
1991
- 1991-10-30 CA CA002071878A patent/CA2071878A1/en not_active Abandoned
- 1991-10-30 RU SU915052287A patent/RU2056423C1/ru active
- 1991-10-30 SK SK2047-92A patent/SK279484B6/sk unknown
- 1991-10-30 WO PCT/HU1991/000046 patent/WO1992007851A1/en not_active Application Discontinuation
- 1991-10-30 JP JP3517150A patent/JPH05503297A/ja active Pending
- 1991-10-30 US US07/877,172 patent/US5352790A/en not_active Expired - Fee Related
- 1991-10-30 EP EP91918864A patent/EP0507914A1/en not_active Ceased
- 1991-10-30 PL PL91295417A patent/PL168526B1/pl unknown
- 1991-10-30 RO RO92-0866A patent/RO109650B1/ro unknown
- 1991-10-30 KR KR1019920701563A patent/KR100211445B1/ko not_active IP Right Cessation
- 1991-11-05 ZA ZA918790A patent/ZA918790B/xx unknown
- 1991-11-16 CN CN91110744A patent/CN1040439C/zh not_active Expired - Fee Related
- 1991-12-06 TW TW080109625A patent/TW223074B/zh active
-
1992
- 1992-06-26 NO NO922545A patent/NO300688B1/no unknown
- 1992-06-30 FI FI923042A patent/FI923042A0/fi not_active Application Discontinuation
- 1992-06-30 CZ CS922047A patent/CZ280718B6/cs not_active IP Right Cessation
- 1992-12-30 LV LVP-92-688A patent/LV10272B/lv unknown
-
1993
- 1993-06-17 GE GEAP1993897A patent/GEP19981536B/en unknown
- 1993-11-25 LT LTIP1487A patent/LT3733B/lt unknown
- 1993-12-10 BG BG098289A patent/BG61894B2/bg unknown
Also Published As
Publication number | Publication date |
---|---|
NO922545D0 (no) | 1992-06-26 |
NO300688B1 (no) | 1997-07-07 |
EP0507914A1 (en) | 1992-10-14 |
GEP19981536B (en) | 1998-11-13 |
RU2056423C1 (ru) | 1996-03-20 |
HU207070B (en) | 1993-03-01 |
LTIP1487A (en) | 1995-06-26 |
TW223074B (no) | 1994-05-01 |
FI923042A (fi) | 1992-06-30 |
WO1992007851A1 (en) | 1992-05-14 |
HU906952D0 (en) | 1991-05-28 |
LV10272B (en) | 1995-10-20 |
ZA918790B (en) | 1992-08-26 |
KR920703588A (ko) | 1992-12-18 |
JPH05503297A (ja) | 1993-06-03 |
RO109650B1 (ro) | 1995-04-28 |
NO922545L (no) | 1992-06-26 |
CZ280718B6 (cs) | 1996-04-17 |
PL168526B1 (en) | 1996-02-29 |
LV10272A (lv) | 1994-10-20 |
CA2071878A1 (en) | 1992-05-01 |
SK279484B6 (sk) | 1998-12-02 |
CS204792A3 (en) | 1992-10-14 |
CN1040439C (zh) | 1998-10-28 |
KR100211445B1 (ko) | 1999-08-02 |
FI923042A0 (fi) | 1992-06-30 |
US5352790A (en) | 1994-10-04 |
CN1072412A (zh) | 1993-05-26 |
LT3733B (en) | 1996-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5101039A (en) | Azabicycloamino carboxylic acid intermediates | |
CA1198118A (en) | Derivatives of cycloalka[c]pyrrolcarboxylic acids, a process for their preparation, agents containing these compounds, and their use, and new cycloalka[c]pyrrolcarboxylic acidsas intermediates, and a process for their preparation | |
US3072530A (en) | Therapeutic indoles for psychic stimulation and relief of mental depression | |
SU510999A3 (ru) | Способ получени (метоксиметил-фурилметил)6,7-бензоморфанов илиморфинанов | |
JPH0236595B2 (no) | ||
EP0230037A1 (en) | Cytoprotective derivatives useful in ischemic diseases, their preparation and compositions containing them | |
EP0219256B1 (en) | N-alkylation of dihydrolysergic acid | |
IL116384A (en) | Iliden assemblies and their preparation | |
FR2515653A1 (fr) | Procede de preparation d'esters d'acides hydroxyimino apovincaminiques, esters ainsi obtenus, et compositions pharmaceutiques preparees avec ces esters | |
BG61894B2 (bg) | Метод за получаване на 1 бета-етил-1 алфа-(хидроксиметил)- 1,2,3,4,6,7,12,12в алфа-октахидор-индоло/2,3-а/-хинолизин и нови междинни съединения | |
SE461653B (sv) | Foerfarande foer framstaellning av aminoeburnanderivat | |
JPS63145286A (ja) | 二環性イミダゾ−ル誘導体 | |
US4169201A (en) | Novel ester precursor intermediates and antipodes for the preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil | |
US4704472A (en) | Preparation of an enantiomer of a substituted fluorenyloxyacetic acid | |
US5446166A (en) | Preparation of pyrrol and oxazole compounds: formation of porphyrins and C-acyl-α-amino acid esters therefrom | |
US3317560A (en) | Indol-3-yl alkylguanidine derivatives | |
EP0646116B1 (en) | Process and intermediates for bis-aza-bicyclic anxiolytic agents | |
SU1097621A1 (ru) | 6,7-Диэтокси-1-(4-этокси-3-оксибензил)-3,4-дигидроизохинолин,обладающий действием на сердечно-сосудистую систему | |
SU497764A3 (ru) | Способ получени производных норборнана | |
US20020198400A1 (en) | Synthesis of 3-amino-3-aryl propanoates | |
KR0150460B1 (ko) | 라세믹 및 광학활성인 옥타히드로-인돌로[2,3-a]테트라히드로 피라닐 [2,3-c]퀴놀리진 디에스테르 유도체와 그의 산부가염 및 그의 제조방법 | |
FI70022C (fi) | Saosom mellanprodukter anvaendbara 2-kloradeninderivat | |
US4162252A (en) | Process for preparing 3-[(benzamidopiperid-1-yl)alkyl] indoles | |
JP3221151B2 (ja) | ピロール誘導体の製造法 | |
GB2048849A (en) | 2 - (3 - mercapto - 1 - oxopropyl) - 5-oxo - 3 - pyrazolidine - 5 - carboxylic acids and esters |